Harris, Paul E. http://orcid.org/0000-0003-4806-8242
Rubsamen, Reid http://orcid.org/0000-0003-4856-2371
Article History
Accepted: 16 April 2024
First Online: 8 May 2024
Declarations
:
: R.R. and P.H. are employees of Flow Pharma, Inc. a biotechnology company engaged in the development of a breast cancer vaccine therapy. R.R. and P.H. receive compensation in cash and stock from Flow Pharma, Inc. R.R. is a co-inventor of issued and pending patents directly or indirectly related to the topic of the submitted manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Not applicable.
: Not applicable.
: During the preparation of this work, the author(s) used chatGPT for proofreading only. After using this service, the author(s) confirm that they have reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.